Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
T cells
Children
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jan/18/2023
Remdesivir
Children
Approved by FDA Experimental Antiviral Jan/18/2023
Mesenchymal stem cells
Children
Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022
REGEN-COV
Children
Emergency use authorization Experimental Antiviral Jun/03/2022
Convalescent plasma
Children
Emergency use authorization Experimental Antiviral May/16/2022
Anakinra 
Children
Recommended by guidelines Used to treat other disease Other treatment Apr/11/2022
Baricitinib
Children
Emergency use authorization Used to treat other disease Other treatment Feb/03/2022
Tocilizumab
Children
Recommended by China's NHC Guidelines Used to treat other disease Other treatment Dec/21/2021
Methylprednisolone
Children
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/21/2021
Corticosteroids
Children
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021
Acetylsalicylic acid
Children
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
IVIg
Children
Potential treatment - clinical evidence Used to treat other disease Other treatment May/23/2021
Regdanvimab
Children
Authorized Experimental Antiviral